These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12766934)

  • 1. Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers.
    Asghar SJ; Tanay VA; Baker GB; Greenshaw A; Silverstone PH
    Hum Psychopharmacol; 2003 Jun; 18(4):291-9. PubMed ID: 12766934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.
    McGrath BM; McKay R; Dave S; Seres P; Weljie AM; Slupsky CM; Hanstock CC; Greenshaw AJ; Silverstone PH
    Neurosci Res; 2008 Aug; 61(4):351-9. PubMed ID: 18508145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate attenuates dextroamphetamine-induced subjective changes more than lithium.
    Willson MC; Bell EC; Dave S; Asghar SJ; McGrath BM; Silverstone PH
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):633-9. PubMed ID: 15949922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
    Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
    Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
    Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
    J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study.
    Silverstone PH; O'Donnell T; Ulrich M; Asghar S; Hanstock CC
    Hum Psychopharmacol; 2002 Dec; 17(8):425-9. PubMed ID: 12457379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
    Turner DC; Clark L; Dowson J; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2004 May; 55(10):1031-40. PubMed ID: 15121488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of modafinil on cognitive and meta-cognitive performance.
    Baranski JV; Pigeau R; Dinich P; Jacobs I
    Hum Psychopharmacol; 2004 Jul; 19(5):323-32. PubMed ID: 15252824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does stress reactivity or response to amphetamine predict smoking progression in young adults? A preliminary study.
    de Wit H; Vicini L; Childs E; Sayla MA; Terner J
    Pharmacol Biochem Behav; 2007 Feb; 86(2):312-9. PubMed ID: 16919319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose of prednisone does not induce amphetamine-like subjective effects in healthy subjects.
    Warot D; Danjou P; Payan C; Rocher J; Brialy N; Puech AJ
    Therapie; 1995; 50(4):307-12. PubMed ID: 7482385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological effects of amphetamine may correlate with personality characteristics.
    Fleming K; Bigelow LB; Weinberger DR; Goldberg TE
    Psychopharmacol Bull; 1995; 31(2):357-62. PubMed ID: 7491392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J; Trick L; Johnsen S; Roach J; Rubens R
    Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
    Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.